Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain

Details for Australian Patent Application No. 2006331734 (hide)

Owner Janssen Pharmaceutical N.V.

Inventors Smith-Swintosky, Virginia L.; Reitz, Allen B.

Agent Shelston IP

Pub. Number AU-A-2006331734

PCT Pub. Number WO2007/075752

Priority 60/751,686 19.12.05 US; 60/773,812 15.02.06 US; 11/612,071 18.12.06 US

Filing date 19 December 2006

Wipo publication date 5 July 2007

International Classifications

A61K 31/352 (2006.01) - condensed with carbocyclic rings, e.g. cannabinols, methantheline

A61K 31/353 (2006.01)

A61K 31/357 (2006.01) - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

10 July 2008 PCT application entered the National Phase

  PCT publication WO2007/075752 Priority application(s): WO2007/075752

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006331742-Methods and systems for leaching and releasing silicone hydrogel ophthalmic lenses with alcohol solutions

2006331733-Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression